Technology Journal of Ohio: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal of Ohio.

Press releases published on October 23, 2026

an hour ago

TokenPulse Opens Singapore APAC Operating Hub

Indeterminate GlobeNewswire

an hour ago

Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026

Indeterminate GlobeNewswire

an hour ago

SHARDOR KM805 Dual-Brew Coffee Maker Now Available: A Single Cup or a 32-Oz Carafe for Holiday Hosts

Indeterminate GlobeNewswire

an hour ago

Gix Internet Shares to Trade Exclusively on Nasdaq

Indeterminate GlobeNewswire

an hour ago

Copilot Readiness Assessments Help Regulated Organizations Check Sensitive File Access

Indeterminate GlobeNewswire

an hour ago

Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials

Indeterminate GlobeNewswire

an hour ago

GigaCloud Technology Inc Ranks Among Top 15 on Fortune’s Fastest Growing Companies™ 2026 and TIME’s America’s Growth Leaders 2027 Lists

Indeterminate GlobeNewswire

an hour ago

Aurora Mobile's EngageLab Brings AI Beyond the Send Button with Agent Email, Letting AI Agents Receive and Answer Customer Replies at Scale

Indeterminate GlobeNewswire

2 hours ago

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

Indeterminate GlobeNewswire

2 hours ago

Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy

Indeterminate GlobeNewswire

2 hours ago

Arrvel Introduces Industrial Barcode Scanner and Handheld Terminal Lineup for Global Enterprises

Indeterminate GlobeNewswire

2 hours ago

2026 ASCII Cup Honors Technology Partners Driving ITSP Success

Indeterminate GlobeNewswire

2 hours ago

Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3

Indeterminate GlobeNewswire

3 hours ago

Logile Hosts Inaugural Connect EMEA Event, Bringing UK Retailers Together Around Connected Stores

Indeterminate GlobeNewswire

4 hours ago

Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA

Indeterminate GlobeNewswire

4 hours ago

Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer

Indeterminate GlobeNewswire

5 hours ago

ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial

Indeterminate GlobeNewswire

5 hours ago

ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

6 hours ago

Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer

Indeterminate GlobeNewswire

6 hours ago

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01

Indeterminate GlobeNewswire